Dr. Amy S. Clark, MD
- Medicare services, 2024
- 327
- Medicare patients, 2024
- 138
- Part D claims, 2024
- 124
- Publications
- 71
- Clinical trials
- 10
- Practice address
- 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104
- Practice phone
- Call (215) 615-4949
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Perelman Center For Advanced Medicine
Multi-specialty group site · Philadelphia, Pennsylvania
Find Dr. Clark's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Amy S. Clark is a medical oncologist in Philadelphia, Pennsylvania
Dr. Clark practices at Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania.
Dr. Clark's NPI, 1356518724, was assigned on May 14, 2008. Dr. Clark holds Pennsylvania license MD440306.
- NPI
- 1356518724NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6507020906
- NPI enumeration date
- May 14, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (215) 615-4949
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Amy S. Clark practices at Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania
Dr. Clark's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104. The practice phone is (215) 615-4949.
- Perelman Center for Advanced Medicine3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104Phone(215) 615-4949
Source: Dmand AI Affiliation Data
Dr. Amy S. Clark is affiliated with 4 sites of care and 1 medical group
Dr. Clark's primary practice is Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania. Dr. Clark is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Clark to 2 more hospitals, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Amy S. Clark's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clark practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Perelman Center For Advanced Medicine | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Amy S. Clark is one of 213 medical oncologists in Pennsylvania
Medical oncology is Dr. Clark's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Clark is licensed in Pennsylvania.
Specialties and state licenses
- Medical oncology, PennsylvaniaPrimary
Medical oncologists near Dr. Clark
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Amy S. Clark billed Medicare for 327 services in 2024
CMS data shows 327 Medicare services from Dr. Clark across 4 procedure codes in 2024, for 138 Medicare patients. Medicare paid $17,009 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Clark's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2252024: 2059%
- Other services
- 2023: 02024: 122
Dr. Clark compared with the Pennsylvania median for medical oncologists, 2024
- Dr. Clark
- Pennsylvania median
- Medicare services
- 327vs 36811% below
- Medicare patients
- 138vs 1487% below
- Part D claims
- 77vs 19260% below
Medians across 201 medical oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Clark's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Clark?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Clark and other medical oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Amy S. Clark treated 138 Medicare patients in 2024, average age 73
CMS counts 138 Medicare patients who saw Dr. Clark in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have cancer, and 67% have high cholesterol. Their average risk score is 1.41, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Clark's median patient age at 66, with 94% women.
Dr. Clark's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Clark's Medicare patients, 2024
- Cancer75%
- High cholesterol67%
- High blood pressure57%
- Arthritis37%
- Anxiety28%
- Mood disorders25%
- Diabetes23%
- Osteoporosis22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Clark's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women94%
- Men5%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Amy S. Clark wrote 124 Medicare Part D claims in 2024
In 2024, Dr. Clark wrote 124 Medicare Part D claims for 42 patients. 81% of them were for generic drugs. CMS names the drug for 77 of them, across 3 drugs with 11 or more claims each, at $196,444 in total drug cost. In 2023, CMS named 62 claims across 2 drugs.
Dr. Clark's Part D claims by kind of drug, 2024
- Generic101 claims81%
- Brand-name23 claims19%
Dr. Clark's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 622024: 7724%
Drugs named by CMS: 3 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Amy S. Clark scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Clark for performance year 2024, reported as part of a group. Dr. Clark accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clark as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Clark's MIPS scores, performance year 2024
- 85of 100Final score
- 73.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Amy S. Clark has 71 publications on record
Dmand AI links 71 papers to Dr. Clark, published from 2011 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Receptor, ErbB-2. Dr. Clark has published most often in JAMA Oncol. Dr. Clark's most frequent co-authors are Angela Demichele, MD, Laura J. Esserman, MD and Rita Nanda.
Dr. Clark's papers by year, 2016 to 2025
Topics Dr. Clark writes about most
- Breast Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Receptor, ErbB-2
- Neoadjuvant Therapy
- Trastuzumab
- Biomarkers, Tumor
- Antineoplastic Agents
- Doxorubicin
Dr. Clark's most frequent co-authors
Recent publications by Dr. Clark
Breast Cancer Res Treat
See who Dr. Clark researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Clark works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Amy S. Clark has worked on 10 clinical trials
Dmand AI links Dr. Clark to 10 clinical trials, 5 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Brain Neoplasms. QuantumLeap Healthcare Collaborative sponsors the most, 2.
Clinical trials with Dr. Clark by phase
- 1Phase 1: 1 trial
- 2Phase 1/2: 2 trials
- 5Phase 2: 5 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Clark's trials
- Breast Neoplasms
- Breast Diseases
- Brain Neoplasms
- Endometrial Neoplasms
- Respiratory Distress Syndrome
Investigators on the most trials with Dr. Clark
- Teja Poosarla, MD3 shared trials
- Ricardo Hugo Alvarez, MD2 shared trials
- Virginia F. Borges, MD2 shared trials
Recent clinical trials with Dr. Clark
Saci-IO HR+: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in Hormone Receptor-positive (HR+) / HER2- Metastatic Breast Cancer (MBC) (opens in a new tab)
A Phase 1b/2 Study of the PARP Inhibitor Niraparib in Combination With Trastuzumab in Patients With Metastatic HER2+ Breast Cancer (opens in a new tab)
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study (opens in a new tab)
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Amy S. Clark received $3,721 in industry payments from 2016 to 2025
CMS Open Payments shows 8 general payments to Dr. Clark from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Sanofi and Genzyme US Companies paid the most, $3,015. It also lists 6 research payments totaling $3,200 from 2017 to 2021.
General payments to Dr. Clark by program year, 2016 to 2025
General payments to Dr. Clark by kind, 2016 to 2025
- Consulting fees$2,82576%
- Food and beverage$63517%
- Grants$2507%
- Education$120%
Companies that paid Dr. Clark the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Amy S. Clark's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Amy S. Clark
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Amy S. Clark's NPI number?
Dr. Amy S. Clark's NPI number is 1356518724. It was assigned on May 14, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Amy S. Clark?
Dr. Amy S. Clark is a medical oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Amy S. Clark practice?
Dr. Clark practices at 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104. Dr. Clark's primary practice is Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania. Dmand AI also links Dr. Clark to 2 hospitals.
What is Dr. Amy S. Clark's office phone number?
The practice phone on file for Dr. Clark is (215) 615-4949.
What is Dr. Amy S. Clark's medical license number?
Dr. Clark holds Pennsylvania license MD440306.
Which hospitals is Dr. Amy S. Clark affiliated with?
Dr. Clark is affiliated with Hospital of the University of Pennsylvania. Dmand AI links Dr. Clark to 2 more hospitals.
What medical group is Dr. Amy S. Clark part of?
Dr. Clark is linked to Penn Medicine Lancaster General Health.
Does Dr. Amy S. Clark accept Medicare?
Yes. CMS data shows Dr. Clark billed Medicare for 327 services in 2024, and Dr. Clark accepts Medicare assignment.
Does Dr. Amy S. Clark offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Clark as offering telehealth services.
What is Dr. Amy S. Clark's MIPS score?
Dr. Clark's MIPS final score for performance year 2024 is 85 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Amy S. Clark see?
CMS counts 138 Medicare patients who saw Dr. Clark in 2024, with an average age of 73.
What services does Dr. Amy S. Clark bill to Medicare?
In 2024, Dr. Clark's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).
What drugs does Dr. Amy S. Clark prescribe most?
In 2024 Medicare Part D data, Dr. Clark's most prescribed drugs by claims were Anastrozole, Letrozole and Ibrance.
Has Dr. Amy S. Clark received payments from drug or device companies?
CMS Open Payments shows $3,721 in general payments to Dr. Clark from 5 companies from 2016 to 2025. The largest total came from Sanofi and Genzyme US Companies.
How long has Dr. Amy S. Clark been practicing?
Dr. Clark graduated from medical school in 2006, 20 years ago.
Does Dr. Amy S. Clark do research?
Dmand AI links 71 publications to Dr. Clark, published from 2011 to 2025. Dr. Clark has worked on 10 clinical trials.
Who does Dr. Amy S. Clark publish with?
Dr. Clark's most frequent co-authors are Angela Demichele, MD (23 shared papers), Laura J. Esserman, MD (15 shared papers) and Rita Nanda (14 shared papers).
Selling to medical oncology practices?
See medical oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card